Generics
Total Trials
65
As Lead Sponsor
53
As Collaborator
12
Total Enrollment
23,018
NCT00236964
Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis
Phase: Phase 3
Role: Lead Sponsor
Start: Feb 23, 2001
Completion: May 30, 2002
NCT06690450
Safety and Tolerability of 200mg and 100mg of Venofer Administered to Hemodialysis(HD) Patients
Phase: Phase 4
Start: Aug 31, 2001
Completion: Feb 28, 2002
NCT00239616
Pharmacokinetic of Intravenous Iron Sucrose in Adolescents on Hemodialysis or Peritoneal Dialysis Receiving Epoetin
Phase: Phase 2
Start: Jun 5, 2002
Completion: Sep 15, 2003
NCT00236938
Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal Dialysis
Start: Jul 31, 2002
Completion: Oct 31, 2004
NCT00087776
Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma
Start: Dec 6, 2002
Completion: Oct 27, 2007
NCT00236951
Intravenous (IV) Iron vs. No Iron as the Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy
Start: Feb 28, 2003
Completion: Dec 31, 2005
NCT00236977
Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia
Start: Aug 31, 2003
NCT00895232
Iron Sucrose In The Treatment of Restless Legs Syndrome: Safety of Three Dose Regimens as Evaluated by Clinical Assessments
Start: Nov 30, 2003
Completion: Nov 30, 2005
NCT00396292
Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in Subjects Who Display Postpartum Anemia
Start: Feb 28, 2005
Completion: Feb 28, 2006
NCT00317239
VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
Start: May 31, 2005
Completion: Aug 31, 2007
NCT00395993
Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding
Completion: Jun 30, 2006
NCT00317226
Long Term Safety Study of (VIT45) Extension Study: Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
Start: Jun 30, 2005
Completion: Sep 30, 2007
NCT00239642
Safety and Efficacy of Iron Sucrose in Children
Start: Jul 31, 2005
Completion: Apr 30, 2010
NCT00740246
Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia
Completion: May 31, 2006
NCT00244816
Taxoprexin® Treatment for Advanced Eye Melanoma
Start: Oct 31, 2005
Completion: Jun 30, 2008
NCT00249262
Taxoprexin Treatment for Advanced Skin Melanoma
Completion: Apr 30, 2007
NCT00243867
Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer
Start: Nov 30, 2005
Completion: Aug 31, 2008
NCT00721188
Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients
Start: Jan 31, 2006
Completion: Jan 31, 2010
NCT01382901
Intravenous (IV) Iron Preparation (VIT-45) in the Treatment of Restless Legs Syndrome (RLS)
Start: Mar 31, 2006
Completion: Jul 31, 2007
NCT00354484
Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients
Start: May 31, 2006
Completion: Jan 31, 2007
NCT00685815
Intravenous Iron Metabolism in Restless Legs Syndrome
Start: Nov 30, 2006
Completion: Dec 31, 2012
NCT00422877
Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary Tract
Start: Jan 31, 2007
Completion: Mar 31, 2008
NCT00548691
Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease Patients
Start: Oct 31, 2007
Completion: Jul 31, 2009
NCT00548860
Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients
NCT01365624
Safety and Pharmacokinetics Study of Intranasal Ketorolac in Elderly and Nonelderly Adult Healthy Subjects
Phase: Phase 1
Start: Feb 29, 2008
Completion: Jul 31, 2008
NCT00704028
Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Iron Dextran in Treating Iron Deficiency Anemia
Start: Jun 30, 2008
Completion: Mar 31, 2011
NCT00704353
Safety and Tolerability of a Single Dose of FCM vs. Standard of Care in Treating Iron Deficiency Anemia
NCT00703937
Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Standard of Care in Treating Iron Deficiency Anemia
Start: Jul 31, 2008
NCT00981045
Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal Function
Start: Aug 31, 2009
Completion: Aug 31, 2011
NCT01290315
Intravenous Ferric Carboxymaltose vs IV Iron Sucrose or IV Iron Dextran in Treating Iron Deficiency Anemia in Women
Completion: Aug 31, 2013
NCT00982007
Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)
Start: Sep 30, 2009
NCT00994318
Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Role: Collaborator
Start: Dec 31, 2009
Completion: Feb 28, 2014
NCT01039844
Study of Weekly LOC-paclitaxel Injection for Melanoma
Completion: Feb 29, 2016
NCT01307007
Hypophosphatemia With Ferric Carboxymaltose Vs. Iron Dextran in Iron Deficiency Secondary to Heavy Uterine Bleeding
Start: Sep 30, 2010
NCT01290302
Blinded Cross-Over Bioequivalence (BE) Trial of Luitpold Azacitidine vs Vidaza
Start: Nov 22, 2010
Completion: Dec 21, 2012
NCT01438372
IV Iron Sucrose vs Oral FeSO4 in Treating IDA in Pediatric IBD
Start: Nov 30, 2011
Completion: Mar 31, 2012
NCT01471639
An Efficacy and Safety Trial of Intranasal Ketorolac in Emergency Department Patients for the Treatment of Acute Pain
Phase: N/A
Completion: Jun 30, 2012
NCT01626235
AMPED Outcomes Registry of Post-ED Pain Management
Start: Jul 31, 2012
Completion: Mar 31, 2014
NCT02478281
Safety, Tolerability, and Pharmacokinetic Study of Methylene Blue Following a 1 mg/kg Intravenous Dose in Healthy Adults
Start: Oct 31, 2012
Completion: Mar 31, 2013
NCT01819610
Pharmacokinetics, Safety, and Efficacy of SPRIX in 12 to 17 Year Old Patients vs. Adult Patients Undergoing Open Surgical Procedures
Start: Feb 28, 2013
Completion: Aug 31, 2014
NCT01807234
Comparison of Ketorolac Nasal Spray to Sumatriptan Nasal Spray and Placebo for Acute Treatment of Migraine
Completion: Dec 31, 2014
NCT01950247
Evaluate the Utility of Serum Hepcidin Levels to Predict Response to Oral or IV Iron
Start: Aug 15, 2013
Completion: Jun 30, 2015
NCT01984554
Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency Anemia
Start: Sep 30, 2013
NCT01911819
A Comparison of Bone Formation With Three Different Bone Graft Materials Following Sinus Graft
Start: Dec 31, 2013
Completion: Jun 30, 2016
NCT02086968
Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia (IDA) Secondary to Inflammatory Bowel Disease (IBD) or Gastric Bypass
Start: Jan 1, 2014
Completion: Oct 31, 2017
NCT02492672
Registry to Evaluate Maintenance Treatment With Venofer in Pediatric Patients With Chronic Kidney Disease
Start: Sep 30, 2014
Completion: Dec 31, 2018
NCT02527213
Double-blind Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy
Start: Jan 30, 2015
Completion: Aug 29, 2016
NCT02397057
Placebo-Controlled Study to Investigate the Efficacy & Safety of Injectafer in the Treatment of RLS
Start: Jan 31, 2015
Completion: Jan 31, 2018
NCT02410213
A Study to Characterize the PK and PD Profile of IV FCM in Pediatric Subjects 1-17 Years Old With IDA
Start: Feb 19, 2015
Completion: Jun 1, 2017
NCT02409459
Blinded Randomized Placebo-Controlled Study Efficacy and Safety of Injectafer in ID Patients With Fibromyalgia
Start: Mar 31, 2015
Completion: Mar 31, 2016
NCT02453334
Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injectafer®
Start: May 23, 2015
Completion: Jan 4, 2018
NCT02569060
Feeding America Intervention Trial for Health--Diabetes Mellitus
Start: Oct 31, 2015
NCT02901314
My Recordable On-Demand Audio Discharge Instructions
Start: Mar 1, 2016
Completion: Mar 30, 2022
NCT03037931
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study
Start: Mar 15, 2017
Completion: Feb 2, 2023
NCT02826681
Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia
Start: Jul 10, 2017
Completion: Jul 1, 2022
NCT02949947
Efficacy of Ferric Carboxymaltose in Gastrointestinal Stromal Tumor (GIST) Patients With Iron Deficiency Anemia (IDA) Receiving Systemic Therapy
Start: Dec 18, 2017
Completion: Mar 6, 2019
NCT03523117
Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDA
Start: Jan 31, 2019
Completion: Jan 29, 2021
NCT04269707
Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Unsatisfactory Response Oral Iron Under Study Protocol 1VIT17044
Start: Nov 19, 2019
NCT04968379
Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency Anemia
Start: Jul 21, 2022
Completion: Dec 12, 2024
NCT05816265
Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure
Start: Jan 24, 2024
Completion: Mar 31, 2027
NCT05677126
Tralement vs. Fixed-dose Trace Element Combination Product in Patients >3 to 17 Years of Age Requiring Long-term PN
Start: Aug 31, 2024
Completion: Aug 26, 2024
NCT05661682
Tralement Versus a Fixed-dose Trace Element Combination Product to Evaluate Manganese Safety
Start: Feb 1, 2025
Completion: Dec 4, 2026
NCT07053475
IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV Approaches
Start: Apr 2, 2025
Loading map...